Literature DB >> 2055808

Continuous versus discontinuous antibiotic therapy: the role of the post-antibiotic effect and other factors.

G K Daikos.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 2055808     DOI： 10.1093/jac/27.2.157

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections.

Authors:  C J Dunn; L B Barradell
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

2.  Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells.

Authors:  W S Champney; C L Tober
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

3.  Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.

Authors:  C E Thorburn; S J Molesworth; R Sutherland; S Rittenhouse
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

4.  Postantibiotic effects and postantibiotic sub-MIC effects of roxithromycin, clarithromycin, and azithromycin on respiratory tract pathogens.

Authors:  I Odenholt-Tornqvist; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

Review 5.  Parenteral aminoglycoside therapy. Selection, administration and monitoring.

Authors:  C R Kumana; K Y Yuen
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

6.  Postantibiotic effects and postantibiotic sub-MIC effects of tilmicosin, erythromycin and tiamulin on erythromycin-resistant Streptococcus suis.

Authors:  Liping Wang; Yuanshu Zhang
Journal:  Braz J Microbiol       Date:  2009-12-01       Impact factor: 2.476
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.